Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis.
- DOI
- 10.1007/s40262-025-01516-1
- Published
- 2025 Jun
- Container
- Clinical pharmacokinetics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40262-025-01516-1,
title = {Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis.},
author = {Magnas P and Bouazza N and Foissac F and Froelicher Bournaud L and Lui G and Carlier N and Da Silva J and Fesenbeckh J and Kanaan R and Honoré I and Martin C and Treluyer JM and Burgel PR and Benaboud S},
year = {2025},
journal = {Clinical pharmacokinetics},
doi = {10.1007/s40262-025-01516-1},
url = {https://doi.org/10.1007/s40262-025-01516-1}
}RIS
TY - JOUR TI - Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis. AU - Magnas P AU - Bouazza N AU - Foissac F AU - Froelicher Bournaud L AU - Lui G AU - Carlier N AU - Da Silva J AU - Fesenbeckh J AU - Kanaan R AU - Honoré I AU - Martin C AU - Treluyer JM AU - Burgel PR AU - Benaboud S PY - 2025 JO - Clinical pharmacokinetics DO - 10.1007/s40262-025-01516-1 UR - https://doi.org/10.1007/s40262-025-01516-1 ER -
APA
P, M., N, B., F, F., L, F. B., G, L., N, C., J, D. S., J, F., R, K., I, H., C, M., JM, T., PR, B., & S, B. (2025). Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis.. Clinical pharmacokinetics. https://doi.org/10.1007/s40262-025-01516-1
Source records
- pubmed · retrieved 2026-09-25T22:15:56.069Z